The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia

Fertility and Sterility

Volumn 94, Issue 2, 2010, Pages 684-689

  Pall, Marita ^a   Azziz, Ricardo ^a,b   Beires, Jorge ^c   Pignatelli, Duarte ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

ACTH stimulation test; androgens; hirsutism; insulin resistance; nonclassic adrenal hyperplasia; oral glucose tolerance test; polycystic ovaries; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; STEROID 21 MONOOXYGENASE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOTROPIN TEST; ECHOGRAPHY; FEMALE; FOLLICULAR PHASE; HIRSUTISM; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; OBSERVATIONAL STUDY; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

17-ALPHA-HYDROXYPROGESTERONE; ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; ADULT; AMENORRHEA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLICLE STIMULATING HORMONE; GLUCOSE TOLERANCE TEST; HIRSUTISM; HUMANS; INSULIN RESISTANCE; LUTEINIZING HORMONE; MIDDLE AGED; OBESITY; OLIGOMENORRHEA; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; STEROID 21-HYDROXYLASE; YOUNG ADULT;

EID: 77953708964     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.06.025     Document Type: Article

References (31)

1. Azziz R., Sanchez L.A., Knochenhauer E.S., Moran C., Lazenby J., Stephens K.C., et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89 (2004) 453-462
2. Speiser P.W., Dupont B., Rubinstein P., Piazza A., and Kastelan A. New MI high frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37 (1985) 650-667
3. Azziz R., Dewailly D., and Owerbach D. Non-classic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78 (1994) 810-815
4. Speiser P.W., Knochenhauer E.S., Dewailly D., Fruzzetti F., Marcondes J.A.M., and Azziz R. A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 71 (2000) 527-534
5. Kahsar-Miller M.D., Nixon C., Boots L.R., Go R.C., and Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75 (2001) 53-58
6. Legro R.S., Bentley-Lewis R., Driscoll D., Wang S.C., and Dunaif A. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87 (2002) 2128-2133
7. Legro R.S., Driscoll D., Strauss III J.F., Fox J., and Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95 (1998) 14956-14960
8. Yildiz B.O., Yarali H., Oguz H., and Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 2031-2036
9. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
10. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., Filandra F.A., Tsianateli T.C., Spina G.G., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84 (1999) 4006-4011
11. Asunción M., Calvo R.M., San Millán J.L., Sancho J., Avila S., and Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85 (2000) 2434-2438
12. Moran C., and Azziz R. 21-Hydroxylase deficient non-classic adrenal hyperplasia: the great pretender. Semin Reprod Med 21 (2003) 295-300
13. Azziz R., Hincapie L.A., Knochenhauer E.S., Dewailly D., Fox L., and Boots L.R. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 72 (1999) 915-925
14. Zawadski J., and Dunaif A. Polycystic ovary syndrome: diagnostic criteria for polycystic ovarian syndrome: towards a rational approach (1992), Blackwell, Boston 377-84
15. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140 (1981) 815-830
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 29 Suppl 1 (2006) S43-S48
17. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
18. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
20. Balen A.H., Laven J.S., Tan S.L., and Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9 (2003) 505-514
21. Jonard S., Robert Y., Cortet-Rudelli C., Pigny P., Decanter C., and Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles?. Hum Reprod 18 (2003) 598-603
22. Lobo R.A., and Goebelsmann U. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. Am J Obstet Gynecol 138 (1980) 720-726
23. Azziz R., and Zacur H.A. 21-Hydroxylase deficiency in female hyperandrogenemia: screening and diagnosis. J Clin Endocrinol Metab 69 (1989) 577-584
24. Kuttenn F., Couillin P., Girard F., Billaud L., Vincens M., Boucekkine C., et al. Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313 (1985) 224-231
25. Feldman S., Billaud L., Thalabard J.C., Raux-Demay M.C., Mowszowicz I., Kuttenn F., et al. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74 (1992) 635-639
26. Moran C., Azziz R., Carmina E., Dewailly D., Fruzzetti F., Ibanez L., et al. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 183 (2000) 1468-1474
27. Azziz R., Waggoner W.T., Ochoa T., Knochenhauer E.S., and Boots L.R. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 70 (1998) 274-278
28. Azziz R., Rafi A., Smith B.R., Bradley Jr. E.L., and Zacur H.A. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. J Clin Endocrinol Metab 70 (1990) 431-436
29. Yildiz B.O., Knochenhauer E.S., and Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 93 (2008) 162-168
30. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
31. Orio F., Vuolo L., Palomba S., Lombardi G., and Colao A. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 60 (2008) 39-51